ArticleLeukemia2025
asxl1 C-terminal truncation and SRSF2 mutation drive leukemogenesis via immune reprogramming.
Lingge Tu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleLeukemia2025
Lingge Tu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.